158 results on '"D'Alise, Anna Morena"'
Search Results
2. Characterization of shared neoantigens in Endometrial Cancer with Microsatellite Instability
3. Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy
4. Supplementary Figure 6 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
5. Data from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
6. Supplementary Figure 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
7. Supplementary Figure 5 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
8. Supplementary Table 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
9. Supplementary Figure 2 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
10. Supplementary Figure 3 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
11. Supplementary Figure 4 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
12. Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses
13. Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine
14. Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
15. Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer
16. Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis
17. Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer
18. Abstract LB196: NOUS-PEV, a personalized cancer immunotherapy targeting neoantigens, induces long lasting, tumor infiltrating memory T cells
19. Table S1 from A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability
20. Data from A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability
21. Supplementary Table S3 from Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells
22. Supplementary Data from A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability
23. Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
24. Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
25. Adenoviral-based vaccine promotes neoantigen-specific CD8 + T cell stemness and tumor rejection
26. Interindividual variation in human T regulatory cells
27. Abstract LB008: Characterization of immune correlates of clinical activity for Nous-209, an off-the-shelf immunotherapy, with pembrolizumab for treatment of tumors characterized by microsatellite instability (MSI)
28. First clinical and immunogenicity results including all subjects enrolled in a phase I study of Nous-209, an off-the-shelf immunotherapy, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability (dMMR/MSI).
29. Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy.
30. Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion
31. A cluster of coregulated genes determines TGF-β—induced regulatory T-cell (Treg) dysfunction in NOD mice
32. Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine
33. The Defect in T-Cell Regulation in NOD Mice Is an Effect on the T-Cell Effectors
34. Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance
35. Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion
36. 410 Phase I interim study results of Nous-209, an off-the-shelf immunotherapy, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability (dMMR/MSI)
37. VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens’ Prediction
38. Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection.
39. A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
40. MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans
41. Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing
42. Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment
43. Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus
44. Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials
45. A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability
46. Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells
47. New viral vectors for infectious diseases and cancer
48. Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries
49. Abstract B105: A cancer vaccine targeting many neoantigens is required for effective eradication of large tumors
50. Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.